![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/4000-1-2-1.jpg\")
<\/p>\n<\/p>\n
Halper Sadeh LLP, a global investor rights law firm, is investigating:<\/p>\n
Principia Biopharma Inc. <\/strong>concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its sale to Sanofi for $100<\/span> per share.<\/p>\n Builders FirstSource, Inc. <\/strong> <\/strong>concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its merger with BMC Stock Holdings, Inc. Under the terms of the agreement, BMC shareholders will receive 1.3125 shares of Builders FirstSource common stock for each share of BMC common stock. <\/p>\n Akcea <\/strong>Therapeutics, Inc. <\/strong> <\/strong>concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its sale to Ionis Pharmaceuticals, Inc. Under the terms of the agreement, Ionis will acquire all of the outstanding shares of Akcea common stock it does not already own, approximately 24%, for $18.15<\/span> per share in cash. <\/p>\n Yintech Investment Holdings Limited <\/strong> <\/strong>concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its sale to a group of rollover shareholders that includes members of Yintech’s management and board of directors. Under the terms of the merger agreement, holders of Yintech ordinary shares will receive $0.365<\/span> in cash per share, and holders of Yintech American depository shares (“ADS”) will receive $7.30<\/span> in cash per ADS.<\/p>\n Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.<\/p>\n Shareholders are encouraged to contact the firm free of charge<\/strong> to discuss their legal rights and options. Please call Daniel Sadeh<\/span> or Zachary Halper<\/span> at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.<\/p>\n Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.<\/p>\n Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n Contact Information: Tags:<\/b> Halper Sadeh LLP
Halper Sadeh LLP
Daniel Sadeh, Esq.<\/span>
Zachary Halper, Esq.<\/span>
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https:\/\/www.halpersadeh.com<\/p>\nSee Campaign: <\/strong>https:\/\/www.halpersadeh.com<\/a>
Contact Information:<\/b>
Halper Sadeh LLP
\nDaniel Sadeh, Esq.
\nZachary Halper, Esq.
\n(212) 763-0060
\nsadeh@halpersadeh.com
\nzhalper@halpersadeh.com<\/p>\n
<\/a>, Wire<\/a>, Legal Newswire<\/a>, United States<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\nDaniel Sadeh, Esq.
\nZachary Halper, Esq.
\n(212) 763-0060
\nsadeh@halpersadeh.com\u00a0
\nzhalper@halpersadeh.com\u00a0<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":" Halper Sadeh LLP, a global investor rights law firm, is investigating: Principia Biopharma Inc. concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its sale to Sanofi for $100 per share. Builders FirstSource, Inc. concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its merger with BMC Stock … Continue reading SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, BLDR, AKCA, YIN<\/span><\/a> Continue Reading